Wednesday, 22 May 2019

New Zealand News

  • Genetically altered cow's milk to address allergies

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Scientists at AgResearch in Hamilton, New Zealand, have bred the first cow in the world to produce high protein milk that may be hypo-allergenic. The cow's milk can exclusively a...Read more

  • Nylon producer Invista to collaborate with LanzaTech

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2012

    Singapore: World-leading nylon producer Invista and biotechnology firm LanzaTech have signed a joint development agreement focused on bio-based butadiene. According to the agreement, Invist...Read more

  • Celgene halts phase III trial of cancer drug Revlimid

    New Zealand |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open-label, phase III ORIGIN trial, which enrolled 450 patients in over 1...Read more

  • Connected care' is the new mantra of APAC healthcare

    New Zealand |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2013

    Health systems around the Asia-Pacific region and beyond are under pressure from the increasing demands of an aging population and rising rates of chronic illness. Many are responding wit...Read more

  • NZ, Aus govt commit $2.5 mn for rheumatic vaccine

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 22 Feb, 2013

    Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumatic fever has been welcomed by the University of Auckland, New Zealand....Read more

  • Mylan to develop, market Biocon generic insulin

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 14 Feb, 2013

    Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generics major, Mylan, based in Pittsburgh, US, to sell its three insulin a...Read more

  • Transplant pig cells into human brain to treat Parkinson's

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

    Singapore: Living Cell Technologies (LCT) has received ethical approval from the New Zealand Ministry of Health's Health and Disability Ethics Committee to proceed with phase I clinical tr...Read more

  • BioSpectrum Asia launches 5th CRO survey

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: After four consecutive successful annual surveys on the developments in the clinical research industry, BioSpectrum Asia has now launched the fifth annual survey of the contract ...Read more

  • Largest NZ drug maker to remain a family business

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    Singapore: Douglas Pharmaceuticals, New Zealand's largest pharmaceutical manufacturer, will continue to remain a family owned business. The company had received a number of purchase offer...Read more

  • Nottingham university gets $25 mn for synthetic biology research

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 15 Nov, 2012

    Singapore: The University of Nottingham has been awarded funding of $4.5 million (£2.9 million) to help make low-carbon fuel. In a move that could potentially revolutionize major UK indu...Read more

  • LCT conducts first implant of regenerative therapy

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

    Singapore: Australia-based Living Cell Technologies (LCT) has implanted regenerative cell therapy NTCELL, a treatment for Parkinson's disease in the first patient in phase I clinical trial....Read more

  • Dr Paul Hutchison: NZ's R&D investment is below OECD's average

    New Zealand |  Influencers | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2012

    Dr Paul Hutchison, a healthcare professional and a parliamentarian from Hunua, New Zealand, has emerged as one-of-the-most influential individuals when it comes to the life science policies...Read more

  • What functional roles do CROs play in APAC?

    New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Fisher & Paykel records profit of $62.40 mn

    New Zealand |  Company results | By BioSpectrum Bureau  | 0 Comment | 23 May, 2013

    Singapore: Fisher & Paykel Healthcare reported record net profit after tax of $62.40 million (NZ$77.1 million) for the year ended March 31, 2013, an increase of 20 percent as compared t...Read more

  • WHO aims to eliminate TB by 2050

    New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2014

    Singapore: WHO along with European Respiratory Society (ERS), has outlined a framework to work on pre-elimination of tuberculosis (TB) in countries with low levels of the disease and target...Read more

  • BSA-CMR Survey: New CRO players emerge in APAC

    New Zealand |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Pictor offers multiple diagnosis with one drop of blood

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2012

    New Zealand-based Dr Sarita Kumble and Dr Anand Kumble wanted to create an affordable diagnostic test platform that could be deployed in those parts of the world with the highest need. The ...Read more

  • ImmusanT starts trials of celiac disease vaccine, Nexvax2

    New Zealand |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: ImmusanT initiated clinical trials in New Zealand, Australia and the US to evaluate Nexvax2, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls